Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents

A Corrigendum to this article was published on 07 January 2015

This article has been updated

Abstract

Obesity and the nitric oxide synthase 3 (NOS3) gene polymorphisms are associated with nitrite levels and hypertension. However, no study has tested the hypothesis that NOS3 tagSNPs rs3918226, rs3918188, rs743506 and rs7830 affect nitrite levels and are associated with hypertension in childhood obesity. We investigated the association of these NOS3 tagSNPs and the haplotypes formed by them with hypertension and with nitrite levels in children and adolescents with obesity and with obesity plus hypertension. We studied 355 subjects: 174 healthy (controls), 109 normotensive obese, and 72 obese children and adolescents with obesity plus hypertension. Genotypes were determined by Taqman allele discrimination assay and real-time PCR. We compared the distribution of NOS3 tagSNP genotypes, alleles and haplotypes in the three groups of subjects. Nitrite levels were determined by ozone-based chemiluminescence. Nitrite levels were affected by the rs3918226 polymorphism (P<0.05) but not by NOS3 haplotypes. There was no association between the tagSNPs studied and hypertension in children and adolescents. Our findings show that the NOS3 tagSNP rs3918226 is associated with NO production in children and adolescents, and suggest that this polymorphism may have an impact on cardiovascular health. Further studies are needed to better clarify the effects of this polymorphism on cardiovascular risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Change history

  • 05 November 2014

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Barlow SE . Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007; 120 (Suppl 4): S164–S192.

    Article  Google Scholar 

  2. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. New Engl J Med 2011; 365 (20): 1876–1885.

    Article  CAS  Google Scholar 

  3. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC . Childhood obesity, other cardiovascular risk factors, and premature death. New Engl J Med 2010; 362 (6): 485–493.

    Article  CAS  Google Scholar 

  4. Gruber HJ, Mayer C, Mangge H, Fauler G, Grandits N, Wilders-Truschnig M . Obesity reduces the bioavailability of nitric oxide in juveniles. Int J Obes 2008; 32 (5): 826–831.

    Article  CAS  Google Scholar 

  5. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA . Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002; 87 (10): 4652–4656.

    Article  CAS  Google Scholar 

  6. Brambilla P, Antolini L, Street ME, Giussani M, Galbiati S, Valsecchi MG et al. Adiponectin and hypertension in normal-weight and obese children. Am J Hypertens 2013; 26 (2): 257–264.

    Article  CAS  Google Scholar 

  7. Diez JJ, Iglesias P . The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148 (3): 293–300.

    Article  CAS  Google Scholar 

  8. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y . Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003; 16 (1): 72–75.

    Article  CAS  Google Scholar 

  9. Belo VA, Souza-Costa DC, Lacchini R, Sertorio JT, Lanna CM, Carmo VP et al. Adiponectin associates positively with nitrite levels in children and adolescents. Int J Obes (Lond) 2013; 37 (5): 740–743.

    Article  CAS  Google Scholar 

  10. Cooke JP, Dzau VJ . Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489–509.

    Article  CAS  Google Scholar 

  11. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H . Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199 (1): 8–17.

    Article  Google Scholar 

  12. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N . Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349 (9055): 837–842.

    Article  CAS  Google Scholar 

  13. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE . Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 2006; 186 (2): 428–432.

    Article  CAS  Google Scholar 

  14. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE . Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 2007; 16 (3): 348–355.

    Article  CAS  Google Scholar 

  15. Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H Jr., Tanus-Santos JE . Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 2006; 24 (12): 2393–2397.

    Article  CAS  Google Scholar 

  16. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE . Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 2006; 189 (1): 241–246.

    Article  CAS  Google Scholar 

  17. Souza-Costa DC, Belo VA, Silva PS, Sertorio JT, Metzger IF, Lanna CM et al. eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes (Lond) 2011; 35 (3): 387–392.

    Article  CAS  Google Scholar 

  18. Kullo IJ, Greene MT, Boerwinkle E, Chu J, Turner ST, Kardia SL . Association of polymorphisms in NOS3 with the ankle-brachial index in hypertensive adults. Atherosclerosis 2008; 196 (2): 905–912.

    Article  CAS  Google Scholar 

  19. Ingelsson E, Syvanen AC, Lind L . Endothelium-dependent vasodilation in conduit and resistance vessels in relation to the endothelial nitric oxide synthase gene. J Hum Hypertens 2008; 22 (8): 569–578.

    Article  CAS  Google Scholar 

  20. Metzger IF, Luizon MR, Lacchini R, Ishizawa MH, Tanus-Santos JE . Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in black subjects. Nitric Oxide 2013; 28: 33–38.

    Article  CAS  Google Scholar 

  21. Johnson T, Gaunt TR, Newhouse SJ, Padmanabhan S, Tomaszewski M, Kumari M et al. Blood pressure loci identified with a gene-centric array. Am J Hum Genet 2011; 89 (6): 688–700.

    Article  CAS  Google Scholar 

  22. Salvi E, Kutalik Z, Glorioso N, Benaglio P, Frau F, Kuznetsova T et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension 2012; 59 (2): 248–255.

    Article  CAS  Google Scholar 

  23. Luizon MR, Metzger IF, Lacchini R, Tanus-Santos JE . Endothelial nitric oxide synthase polymorphism rs3918226 associated with hypertension does not affect plasma nitrite levels in healthy subjects. Hypertension 2012; 59 (6): e52 (author reply e53).

    Article  CAS  Google Scholar 

  24. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R et al. CDC growth charts: United States. Adv Data 2000; 314: 1–27.

    Google Scholar 

  25. Salvi E, Kuznetsova T, Thijs L, Lupoli S, Stolarz-Skrzypek K, D'Avila F et al. Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene. Hypertension 2013; 62 (5): 844–852.

    Article  CAS  Google Scholar 

  26. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005; 12 (3): 177–182.

    Article  CAS  Google Scholar 

  27. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18 (6): 499–502.

    CAS  Google Scholar 

  28. Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE . eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 2006; 41 (7): 1044–1049.

    Article  CAS  Google Scholar 

  29. Metzger IF, Sertorio JT, Tanus-Santos JE . Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol (Oxf) 2006; 188 (2): 123–127.

    Article  CAS  Google Scholar 

  30. Ghasemi A, Zahediasl S, Azizi F . Nitric oxide and clustering of metabolic syndrome components in pediatrics. Eur J Epidemiol 2010; 25 (1): 45–53.

    Article  CAS  Google Scholar 

  31. Zahedi Asl S, Ghasemi A, Azizi F . Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem 2008; 41 (16-17): 1342–1347.

    Article  CAS  Google Scholar 

  32. Siervo M, Bluck LJ . In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome. Metabolism 2012; 61 (5): 680–688.

    Article  CAS  Google Scholar 

  33. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003; 35 (7): 790–796.

    Article  CAS  Google Scholar 

  34. Yetik-Anacak G, Catravas JD . Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol 2006; 45 (5): 268–276.

    Article  CAS  Google Scholar 

  35. Gomes VA, Casella-Filho A, Chagas AC, Tanus-Santos JE . Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. Nitric Oxide 2008; 19 (4): 345–350.

    Article  CAS  Google Scholar 

  36. Huang PL . eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 2009; 20 (6): 295–302.

    Article  CAS  Google Scholar 

  37. Wu G, Meininger CJ . Nitric oxide and vascular insulin resistance. Biofactors 2009; 35 (1): 21–27.

    Article  Google Scholar 

  38. Korda M, Kubant R, Patton S, Malinski T . Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 2008; 295 (4): H1514–H1521.

    Article  CAS  Google Scholar 

  39. Oak JH, Cai H . Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 2007; 56 (1): 118–126.

    Article  CAS  Google Scholar 

  40. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ . Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278 (45): 45021–45026.

    Article  CAS  Google Scholar 

  41. Guerre-Millo M . Adiponectin: an update. Diabetes Metab 2008; 34 (1): 12–18.

    Article  CAS  Google Scholar 

  42. Goncalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS et al. Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol 2011; 30 (6): 363–369.

    Article  CAS  Google Scholar 

  43. Muniz L, Luizon MR, Palei AC, Lacchini R, Duarte G, Cavalli RC et al. eNOS tag SNP haplotypes in hypertensive disorders of pregnancy. DNA Cell Biol 2012; 31 (12): 1665–1670.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was funded by Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP-Brazil) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-Brazil).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J E Tanus-Santos.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Miranda, J., Lacchini, R., Belo, V. et al. The effects of endothelial nitric oxide synthase tagSNPs on nitrite levels and risk of hypertension and obesity in children and adolescents. J Hum Hypertens 29, 109–114 (2015). https://doi.org/10.1038/jhh.2014.48

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2014.48

This article is cited by

Search

Quick links